// App-Quantinova.ai

: CSF neurodegeneration biomarkers predict MTL atrophy over time in cognitively healthy older adults

Researchers

Presenter

  • Elettra Capogna

Principal Investigators

  • Øystein Sørensen

  • Kaj Blennow

  • Nathalie Halaas

  • Ane-Victoria Idland

  • Athanasia M Mowinckel

  • Joana B Pereira

  • Leiv Otto Watne

  • Henrik Zetterberg

  • Kristine B Walhovd

  • Anders M Fjell

Medical Centers

  • University of Oslo

  • Hong Kong Center for Neurodegenerative Diseases

  • Harvard University, MA.

  • Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • University of Oslo

  • University of Oslo, Department of Psychology

  • Odense University Hospital

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Oslo Delirium Research Group

  • UK Dementia Research Institute

  • Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy, University of Gothenburg

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

Locations

  • Norway

  • Hong Kong

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved